Applications Published 23 May 2001

Published: 8-Mar-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Integrin receptor antagonists
    Merck 1100506*

  • Antioxidant compsn and method of treating diseases using same
    HME Enterprises 1100507*

  • Pharmaceutical combination comprising a tricyclic compound and at least one of zolopidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders
    Takeda Chemical Industries 1100508*

  • Use of biogenic estrogen sulfamates for hormone replacement therapy
    Jenapharm 1100509*

  • Combined preparation of of anti-infectiously active compounds which inhibit the 2-C-methyleryhtrose-4 metabolic pathway and inhibitors of lipid metabolism
    Jomaa, Hassan 1100510*

  • Inhibition of delta-9-desaturase activity by saponins
    Chavali, Sambasiva 1100511*

  • Preparation of thioarabinofuranosyl compounds and use thereof
    Southern Research Institute 1100512*

  • Autoinducer synthase modulating compounds and uses thereof
    University of Iowa Research Foundation 1100513*

  • Injectable anaesthetic containing noble gas
    Messer Griesheim 1100514*

  • Ex vivo treatment of allogenic and xenogeneic T-cells with BP39 antagonists
    Regents of the University of Minnesota 1100515*

  • Extracts of feverfew (Tanacetum parthenium) against inflammatory disorders
    Johnson & Johnson 1100516*
  • You may also like